Breast Health is all about Prevention and Early Detection
Building Trustworthy Artificial Intelligence-based & Risk-Informed Breast Health e-Clinic on Smartphone.
The Challenge
Every 14 seconds, a woman is diagnosed with breast cancer somewhere in the World according to the World Health Organization.
Most breast tumors are discovered by women themselves although no necessarily through breast self-examination.
Reducing global breast cancer mortality by 2.5% per year would avert 25% of breast cancer deaths by 2030 and 40% by 2040 among women under 70 years of age.
Our Solution
Breast Cancer is highly curable and it can be successfully treated if detected at an early stage. It can be even avoided through effective breast health education, awareness and prevention.
“Knowing My Normal” is the key component of the breast health awareness which is crucial to breast cancer risk prediction and early detection. This is the heart of HOPE, the Smart Risk-Informed Breast Health e-Clinic on Smartphone.
HOPE VALLEY AI has been founded in April 2024 in La Rochelle (France) by Dr Hakima BERDOUZ, CEA Researcher, and Delphine REMY-BOUTANG, Investor and Serial Entrepreneur.
Our patented technology is the result of over 12 years of R&D at CEA and of more than 3,5 years, fully devoted to Deeptech maturation and building Trustworthy Artificial Intelligence for HealthTech, with the support of CEA Paris-Saclay, Université Paris-Saclay, INRIA Start-up Studio Paris, AP-HP, Paris-Saclay Cancer Cluster (PSCC) and the Prevent2Care Lab Program.
Our Mission
Building Trustworthy Artificial Intelligence (AI) to help primary healthcare providers to save lives with 5-year and 12-month breast cancer risk prediction and with early detection of weak signals of incubation of breast cancer before it occurs.
Proud to be backed by
and committed business angels, partners and sponsors.
2024 Hope Valley AI. All rights reserved.
Privacy Policy